{"name":"HepaRegeniX GmbH","slug":"heparegenix-gmbh","ticker":"","exchange":"","domain":"heparegenixgmbh.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxQbDRpV1FoeFJHRXBrZTRRcUMzTFBOTGtVVzZtUWJ6ckZlUnptc0RoTTFYUGtOZjd3VTJnajdBbWdGdGg4Qk9odUw3b0JPUUVwSTZLR0REbWFucE9mMjZXWEdrYzE2N1RkNmlvUHBXeWZyMkNYQVVXVURGb1ZvM3RaQjA2SnlrQU1GM1NtNEFKZk10amtnaW5Ra1NSZHhQbjFyeHBKSkRWS2E3NDd4UGplLWwyR19xQ1Rma1YzRTEwYVpYcGp6b2NSV2k2ZmpmUnBsQk9kMzJFOHRPN3ZPd1FsWFVhNm94WjNsTTBaVlc1YmxJRzVEMFRXUkpTWHRzTUVHR2YtUU5laXA0UFBmMFhCekpkQTB3OVpo?oc=5","date":"2025-06-10","type":"trial","source":"GlobeNewswire","summary":"HepaRegeniX Doses First Patient in Phase Ib Trial with - GlobeNewswire","headline":"HepaRegeniX Doses First Patient in Phase Ib Trial with","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPckVZdUR5UG1jeWRoUGF6NnJiN1VoLTh6VmJQVmNoS0NiT2VXTnl0c2FFZXJRM3ozcU9FeVJubnpRU3FINFQ3dGVTZ196dTc4SnAwbzNTWU4wMElXT0FueDQ2NXVFdUNOdEpXczBPbV84YUlqNzlvNHZrX2dIVm9VZE1ZakNSUWQ5RUY2Y3B2dHozNGtTeDhKT1FJR1Q0T3MxaHYzWGtqTkt1c1AzVDB6cWxYNGdwZV9uVzV6ZF9qTDFScWpNMHBDNHktMTllTEFOVmx0MTNielZMZENyWUU0d0ZpekxIal9lRFZ6Nm1Cd2U?oc=5","date":"2025-05-22","type":"pipeline","source":"European Medical Journal","summary":"New Kids on the Block: Peroxisome Proliferator-Activated Receptor Agonists in Primary Biliary Cholangitis - European Medical Journal","headline":"New Kids on the Block: Peroxisome Proliferator-Activated Receptor Agonists in Primary Biliary Cholangitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE9EVEJnRXl5Uk4tMlladDNIQjY3YkVLQU9iNEp3LTNhaWM4REFQOHNHbEpPNUZGeVRORGhIdjJRNkJyS1RlRmNfa2pKbXkxcS1idVM1OUF3?oc=5","date":"2025-04-15","type":"pipeline","source":"The Pharma Letter","summary":"HepaRegeniX - The Pharma Letter","headline":"HepaRegeniX","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNZVhIbXhlUUlKTkd1ODVhVjNVQmJGcWVsX3pOYzN0OUNLb1VDZjZtLXFSRzZXZkEyLVd5VEZtdDVYeV93Mm9TYlFvSTdqc05ScnFidUNlbEhHaUVjNkRwblpwZUhDM3RPRm1ETk5DZmg2RkxmUktwSTlZWllpTEFRVFpiamJ3Z0Njbi0wVHRYZThNZmd1VDUyUU9zb3pGcW1RSm9aemwtSmNNcGEtc0JGeEdUdk1aUHBLYXlvd0tsV2RQT3lBWHhyOV9fODNhR2V6Z21DY2wyZVpLVTZnSzNzRURYTXdsUV9RUTExMVI2Mnh6cFdaamc?oc=5","date":"2024-09-24","type":"pipeline","source":"European Medical Journal","summary":"Progressive Familial Intrahepatic Cholestasis in Adulthood: Genetics, Diagnosis, Treatment, and Further Research - European Medical Journal","headline":"Progressive Familial Intrahepatic Cholestasis in Adulthood: Genetics, Diagnosis, Treatment, and Further Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPWnJoa0VWVFJENDMwcXJXNWI3QUxFbEViYktDUTNLeGZ0aG14aDd5RFl4djFvSHJxYmlVVmtLc1dZSmJMYmpMbVFmX3I4NU5LWEN0TXRVakYweU1PdXhOOTgzZjhZMmJtYV84bDYwTHJpeFZLUy1XSktCQ2Z6aGhGOVBYZG1NUWlINTlrNU40VFF5SXBpczZLT0pLVkk5OW55Y2hGak9pdnlKR3lCdEE?oc=5","date":"2023-08-18","type":"pipeline","source":"Pharmafile","summary":"Dr Michael Lutz appointed as new chief executive officer of iotaSciences - Pharmafile","headline":"Dr Michael Lutz appointed as new chief executive officer of iotaSciences","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}